Catalyst Wire Dossier Catalyst Wire Dossier

Mavyret

glecaprevir/pibrentasvir · AbbVie
Drug timelines are a Plus or Pro feature.

19 regulatory and trial events tracked for Mavyret, covering 2017-08-03 to 2025-06-10. Get the full timeline:

Most recent: FDA Approved: MAVYRET — Supplemental Application (AbbVie Inc.)

See pricing